ganirelix acetate

ganirelix acetate (FYREMADEL) is an FDA-listed pharmaceutical active ingredient. Associated with Amphastar France Pharmaceuticals. Route of administration: injection. Current US regulatory status: approved.

FYREMADEL is a marketed brand name for ganirelix acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

ganirelix acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.